Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
August 10, 2026

[vc_row][vc_column][vc_single_image image="69584" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Circulating tumor cells (CTCs) present a major problem for cancer treatment since they cause therapy resistance and metastasis, the main reasons for cancer-related deaths. By creating experimental models based on CTCs, it will be possible to study CTC biology and...

, , , ,

by
Blog
September 20, 2021

[vc_row][vc_column][vc_single_image image="44750" img_size="full" alignment="center"][vc_column_text]Immune checkpoint inhibitor (ICI) drugs, such as the PD-1inhibitors nivolumab and pembrolizumab, have provided unprecedented survival to patients in many types of cancer in recent years and are used for late-stage cancer treatment worldwide. Unfortunately, many patients who responded well to initial treatments gradually...

, , , ,